Ide T T - OmicsDI

Show results for

Unknown (980)
Genomics (18)
Proteomics (15)
Transcriptomics (14)
Metabolomics (3)
Other (1)

Organisms

Homo sapiens (17)
Mus musculus (7)
Rattus norvegicus (3)
Thermus thermophilus HB8 (1)
Mycolicibacterium smegmatis MC2 155 (1)
Sus scrofa domesticus (1)

Organisms

Homo sapiens (10)
Hepatitis B virus (1)

Repository

ENA (16)
geo (11)
pride (11)
biostudies-arrayexpress (6)
MassIVE (3)
MetaboLights (2)
EGA (1)
GNPS (1)

Tissue

Blood plasma (2)
Cell culture (2)
Ciliary processes (1)
Epithelial cell (1)
Heart (1)
Liver (1)
Lung (1)
Pancreatic islet (1)
Pancreatic islet cell (1)
Tendon (1)
Tendon cell (1)

Disease

Breast cancer (1)
Ciliopathy (1)
Multiple myeloma (1)
Type 2 diabetes mellitus (1)

Technology Type

Mass Spectrometry (11)
Shotgun proteomics (7)
Mass spectrometry (2)
Affinity purification coupled with mass spectrometry proteomics (2)
Bottom-up proteomics (2)
Affinity proteomics (1)
Data-dependent acquisition (1)
Data-independent acquisition (1)
Olink affinity proteomics (1)

Instrument Platform

SolariX (2)
NextSeq 500 (1)
LTQ Orbitrap (1)
LTQ Orbitrap Elite (1)
LTQ Orbitrap Velos (1)
Q Exactive (1)
Flow injection analysis MS - negative (1)
Flow injection analysis MS - positive (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - alternating (1)

Publication Date

2025 (6)
2026 (5)
2023 (4)
2022 (3)
2014 (3)
2024 (3)
2016 (3)
2021 (2)
2013 (1)
2012 (1)
2007 (1)
2018 (1)
2020 (1)

CHEBI ID

CHEBI:15603 (2)
CHEBI:16015 (2)
CHEBI:16414 (2)
CHEBI:16643 (2)
CHEBI:16857 (2)
CHEBI:17115 (2)
CHEBI:17191 (2)
CHEBI:17203 (2)
CHEBI:17295 (2)
CHEBI:17754 (2)
CHEBI:17775 (2)
CHEBI:17895 (2)
CHEBI:18019 (2)
CHEBI:18050 (2)
CHEBI:28716 (2)
CHEBI:30769 (2)
CHEBI:10048 (1)
CHEBI:10049 (1)
CHEBI:103211 (1)
CHEBI:104012 (1)
CHEBI:104121 (1)
CHEBI:104362 (1)
CHEBI:11060 (1)
CHEBI:111006 (1)
CHEBI:1148 (1)
CHEBI:1157 (1)
CHEBI:12936 (1)
CHEBI:12962 (1)
CHEBI:13389 (1)
CHEBI:1372 (1)

Metabolite Name

Ornithine (2)
(2R,4S)-2-methyl-2,3,3,4-tetrahydroxytetrahydrofuran (1)
(R)-2,3-Dihydroxy-3-methylbutanoate (1)
(R)-2,3-Dihydroxy-3-methylpentanoate (1)
(R)-Glycerate (1)
(R)-Pantoate (1)
(R)-Pantothenate (1)
(S)-2-Aceto-2-hydroxybutanoate (1)
(S)-3-Hydroxydodecanoyl-CoA (1)
(S)-3-Hydroxyhexanoyl-CoA (1)
(S)-3-Hydroxyoctanoyl-CoA (1)
(S)-3-Methyl-2-oxopentanoate (1)
1,2-Diacyl-sn-glycerol (dihexadecanoyl, n-C16:0) (1)
1,5-Anhydroglucitol (1)
1-Aminopropan-2-ol (1)
1-Pyrroline-5-carboxylate (1)
1-deoxy-D-xylulose (1)
1-deoxy-D-xylulose 5-phosphate (1)
1-dodecanoyl-sn-glycerol 3-phosphate (1)
1-octadecanoyl-sn-glycerol 3-phosphate (1)
10-Formyltetrahydrofolate (1)
2,3,4,5-Tetrahydrodipicolinate (1)
2,3-Dihydrodipicolinate (1)
2,3-dihydroxycinnamic acid (1)
2-(Formamido)-N1-(5-phospho-D-ribosyl)acetamidine (1)
2-C-methyl-D-erythritol 4-phosphate (1)
2-Dehydropantoate (1)
2-Deoxy-D-ribose 1-phosphate (1)
2-Deoxy-D-ribose 5-phosphate (1)
2-Hydroxy-3-oxopropanoate (1)

First Public Date

2026 (4)
2025 (4)
2023 (3)
2024 (1)
2021 (1)
2019 (1)
2018 (1)
2014 (1)

Classification

viruses (1)

Modification

Not available (1)

Study type

Transcription profiling by array (5)
RNA-seq of coding RNA from single cells (1)

Release Date

2025 (133)
2022 (127)
2021 (118)
2023 (117)
2024 (79)
2020 (67)
2018 (52)
2017 (50)
2019 (49)
2016 (47)
2015 (33)
2014 (29)
2026 (16)
2013 (14)
2012 (13)
2010 (13)
2011 (12)
2008 (5)
2009 (4)
2007 (3)
2004 (2)
2002 (2)
2005 (1)

Lab affiliation

Centre for Drug Safety Science, Dept Pharmacology and Therapeutics, Institute for Systems, Molecular and Integrative Biology, University of Liverpool (1)
Centre for Drug Safety Science, Dept Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool (1)
Icahn School of Medicine at Mount Sinai (1)
Institut Mondor de Recherche Biomédicale, INSERM, U955, 94010 Créteil, France Université Paris Est Créteil, 94010, Créteil, France (1)
Institute for Diabetes and Endocrinology (IDE) Helmholtz Zentrum München Ingolstaedter Landstr. 1 85764 Neuherberg, Germany (1)
Institute of Molecular Medicine and Cell Research, University of Freiburg, Stefan Meier Strasse 17, 79104, Freiburg, Germany (1)
Lab Head of Necker Proteomics Platform (1)
Medical Bioanalytics Institute for Ophthalmic Research Eberhard-Karls-University Tuebingen (1)
Proteomics Platform Necker, Université Paris Cité - Structure Fédérative de Recherche Necker, INSERM US24/CNRS UAR3633, Paris 75015, France. (1)
University of Cadiz (1)
University of Zurich, Institute of Medical Microbiology, Zurich, Switzerland (1)

Previous page
1 / 104
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 104
Next page

Sort by:

Relevance

Page size

Longitudinal Olink affinity proteomics profiling of cytokine release syndrome in myeloma patients receiving BCMA-directed CAR-T therapy

This submission contains de-identified Olink NPX affinity proteomics data from longitudinal peripheral blood samples collected from patients with relapsed/refractory multiple myeloma treated with BCMA-directed CAR-T therapy (ide-cel or cilta-cel) in a prospective single-center pilot study. Samples w...

ORGANISM(S): Homo sapiens (Human)

2026-04-28 | PAD000041 | Pride

Dynamic shift in trophoblast nucleos(t)ide metabolism, transport, and adenosine signaling during gestion and preterm birth

PRJNA1232198 | ENA

miRNA expression signatures in chronic hepatitis B (CHB) treated with nucleos(t)ide analogues (NA)

PRJNA433193 | ENA

Dynamic shift in trophoblast nucleos(t)ide metabolism, transport, and adenosine signaling during gestion and preterm birth

This study investigates the role of nucleos(t)ide metabolism, transport, and adenosine signaling in placental development and spontaneous preterm birth (PTB). We analyzed gene expression in human placentas, primary trophoblasts, BeWo cells and rat placentas across different gestational stages to und...

ORGANISM(S): Homo sapiens Rattus norvegicus

2025-03-08 | GSE291205 | GEO

Real-life experiences with CAR T-cell therapy with idecabtagene vicleucel (ide-cel) for triple-class exposed relapsed/refractory multiple myeloma patients.

Not available

S-EPMC10105393 | biostudies-literature

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes.

Not available

S-EPMC5900846 | biostudies-literature

Dynamic shifts in trophoblast nucleos(t)ide metabolism, transport, and adenosine signaling during gestation and preterm birth.

Not available

S-EPMC12361576 | biostudies-literature

Caucasian Ethnicity, but Not Treatment Cessation is Associated with HBsAg Loss Following Nucleos(t)ide Analogue-Induced HBeAg Seroconversion.